Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(100.0%)
2Total
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05614648Phase 3Terminated

Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet

Role: lead

NCT03727100Phase 3Completed

Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Role: lead

NCT03776318Completed

Long-Term Follow-up Safety of Clonidine Micropellets

Role: lead

All 3 trials loaded